Clinical Trials · NCT05502562
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 388
- Start date
- Feb 2023
- Locations
- See registry
- Primary endpoint
- Change in Glycated haemoglobin A1c (HbA1c)